This panel comprises key opinion leaders assembled on-stage discussing pre-symptomatic illness detection technology development. The forum will cover user needs, technical advances, FDA interactions, hurdles to commercialization, advances in pre-symptomatic detection modalities, etc.
Jane Bearinger, PhD and Justin Yang, MBA – Biomedical Advanced Research and Development Authority (BARDA)
Steve Xu, MD – Sonica Health
Sriram Muthukumar, Ph.D – EnLiSense
Chelsea Tengrove, Ph.D – Empatica
Chris Puleo – GE Global Research
Mehdi Javanmard – RizLab Health
Tom Soh, Ph.D – Stanford University